Literature DB >> 11561146

Protein transfection of intact microvessels specifically modulates vasoreactivity and permeability.

J H Tinsley1, D C Zawieja, M H Wu, E E Ustinova, W Xu, S Y Yuan.   

Abstract

Precise regulation of microvascular tone and barrier function is essential for proper coronary perfusion and performance. Agonist-induced alterations in either or both of these functions ultimately lead to microcirculatory dysfunction and cardiac insufficiency. Two important pathways involved in regulating vasomotor response and barrier function are the activation of nitric oxide synthase (NOS) and upregulation of protein kinase C (PKC). To date, studies of these two signaling proteins have relied mainly on pharmacological approaches. Unfortunately, the specificity of various inhibitors can be cause for concern. In order to address this problem, a protein transfection technique we developed for cultured endothelial cells has been modified and applied to isolated, intact coronary microvessels. Our results from green fluorescent protein transfection in arterioles and venules showed that this procedure could be used to introduce proteins into the microvascular wall. By transfecting inhibitor peptides against NOS and PKC into coronary arterioles and venules, we have been able to determine the specific roles of these two enzymes in vasodilation and hyperpermeability responses. Copyright 2001 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11561146     DOI: 10.1159/000051077

Source DB:  PubMed          Journal:  J Vasc Res        ISSN: 1018-1172            Impact factor:   1.934


  12 in total

1.  Transference of recombinant VE-cadherin cytoplasmic domain alters endothelial junctional integrity and porcine microvascular permeability.

Authors:  Mingzhang Guo; Mack H Wu; Harris J Granger; Sarah Y Yuan
Journal:  J Physiol       Date:  2004-01-01       Impact factor: 5.182

Review 2.  Targeting antibodies to the cytoplasm.

Authors:  Andrea L J Marschall; André Frenzel; Thomas Schirrmann; Manuela Schüngel; Stefan Dübel
Journal:  MAbs       Date:  2011-01-01       Impact factor: 5.857

Review 3.  Myosin light chain kinase in microvascular endothelial barrier function.

Authors:  Qiang Shen; Robert R Rigor; Christopher D Pivetti; Mack H Wu; Sarah Y Yuan
Journal:  Cardiovasc Res       Date:  2010-05-17       Impact factor: 10.787

Review 4.  Myosin light chain kinase signaling in endothelial barrier dysfunction.

Authors:  Robert R Rigor; Qiang Shen; Christopher D Pivetti; Mack H Wu; Sarah Y Yuan
Journal:  Med Res Rev       Date:  2012-08-09       Impact factor: 12.944

5.  Delivery of antibodies to the cytosol: debunking the myths.

Authors:  Andrea L J Marschall; Congcong Zhang; André Frenzel; Thomas Schirrmann; Michael Hust; Franck Perez; Stefan Dübel
Journal:  MAbs       Date:  2014-05-21       Impact factor: 5.857

Review 6.  Neutrophil transmigration, focal adhesion kinase and endothelial barrier function.

Authors:  Sarah Y Yuan; Qiang Shen; Robert R Rigor; Mack H Wu
Journal:  Microvasc Res       Date:  2011-08-16       Impact factor: 3.514

7.  Involvement of ROCK-mediated endothelial tension development in neutrophil-stimulated microvascular leakage.

Authors:  Jerome W Breslin; Hengrui Sun; Wenjuan Xu; Charles Rodarte; Alan B Moy; Mack H Wu; Sarah Y Yuan
Journal:  Am J Physiol Heart Circ Physiol       Date:  2005-09-19       Impact factor: 4.733

Review 8.  Endothelial focal adhesions and barrier function.

Authors:  Mack H Wu
Journal:  J Physiol       Date:  2005-09-29       Impact factor: 5.182

9.  The protein kinase MEK1/2 mediate vascular endothelial growth factor- and histamine-induced hyperpermeability in porcine coronary venules.

Authors:  Mack H Wu; Sarah Y Yuan; Harris J Granger
Journal:  J Physiol       Date:  2004-11-11       Impact factor: 5.182

10.  Focal adhesion kinase mediates porcine venular hyperpermeability elicited by vascular endothelial growth factor.

Authors:  Mack H Wu; Mingzhang Guo; Sarah Y Yuan; Harris J Granger
Journal:  J Physiol       Date:  2003-08-29       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.